New CEO for Magellan Biosciences

2/24/10

Diagnostics company Magellan Biosciences announced today it has appointed a new president and CEO, Hiroshi Uchida. Most recently serving as executive VP, CTO, and a member of the board of directors of blood transfusion technology company Fenwal, Uchida said he plans to improve partnerships and accelerate investments in development projects for Chelmsford, MA-based Magellan, which has products in lead poisoning, food safety, and autoimmune testing.

By posting a comment, you agree to our terms and conditions.